Brief: Oncosec Announces Exclusive License Agreement For Cliniporator® Gene Electrotransfer Platform Developed By Igea Clinical Biophysics
24/11/2020 14:16
Nov 24 (Reuters) - OncoSec Medical Inc ONCS.O :
* ONCOSEC ANNOUNCES EXCLUSIVE LICENSE AGREEMENT FOR
CLINIPORATOR®
GENE ELECTROTRANSFER PLATFORM DEVELOPED BY IGEA CLINICAL
BIOPHYSICS
* ONCOSEC MEDICAL INC - CLINIPORATOR CLEARED FOR USE IN
PHASE 1
CLINICAL TRIAL INVESTIGATING CORVAX12 BY FDA
Source text for Eikon: ID:nPn4JyJ4sa
Further company coverage: ONCS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OncoSec Medical Incorporated
See all newsBrief: OncoSec Medical Inc On June 15 Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
U.S. STOCKS ON THE MOVE-Domino's, Aldeyra, MicroVision
Brief: OncoSec Medical Files Voluntary Petition For Relief Under Provisions Of Chapter 7 Of Title 11 Of United States Code
Brief: OncoSec Medical Terminates George Chi For Cause As Employee, CFO
Brief: Oncosec Medical Receives Non Compliance Notice From Nasdaq